Inventor
WEISSMAN DREW
US29 patents
⚠️ This page may combine multiple inventors who share the name “WEISSMAN DREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
20 patentsUS10232055B2Mar 19, 2019
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA96 citations99
US8835108B2Sep 16, 2014
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA207 citations99
US8748089B2Jun 10, 2014
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA227 citations99
US9750824B2Sep 5, 2017
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA59 citations98
US9371511B2Jun 21, 2016
RNA preparations comprising purified modified RNA for reprogramming cells
UNIV PENNSYLVANIA9 citations92
US11060107B2Jul 13, 2021
Purification and purity assessment of RNA molecules synthesized with modified nucleosides
UNIV PENNSYLVANIA13 citations86
US11028370B2Jun 8, 2021
RNA preparations comprising purified modified RNA for reprogramming cells
UNIV PENNSYLVANIA4 citations84
US10006007B2Jun 26, 2018
RNA preparations comprising purified modified RNA for reprogramming cells
UNIV PENNSYLVANIA9 citations84
US9163213B2Oct 20, 2015
RNA preparations comprising purified modified RNA for reprogramming cells
UNIV PENNSYLVANIA10 citations84
US11801314B2Oct 31, 2023
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA1 citations73
US11739300B2Aug 29, 2023
RNA preparations comprising purified modified RNA for reprogramming cells
UNIV PENNSYLVANIA1 citations73
US11389547B2Jul 19, 2022
RNA containing modified nucleosides and methods of use thereof
UNIV PENNSYLVANIA1 citations73
US11241490B2Feb 8, 2022
Nucleoside-modified RNA for inducing an immune response against zika virus
UNIV PENNSYLVANIA4 citations70
US12054734B2Aug 6, 2024
Purification and purity assessment of RNA molecules synthesized with modified nucleosides
UNIV PENNSYLVANIA0 citations62
US12161709B2Dec 10, 2024
Compositions for inducing an immune response against zika virus
UNIV PENNSYLVANIA0 citations60
US11793872B2Oct 24, 2023
Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof
UNIV PENNSYLVANIA0 citations60
US11141478B2Oct 12, 2021
Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof
UNIV PENNSYLVANIA0 citations60
US12138305B2Nov 12, 2024
Nucleoside-modified RNA for inducing an adaptive immune response
UNIV PENNSYLVANIA0 citations58
US12226471B2Feb 18, 2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus
UNIV PENNSYLVANIA0 citations55
US11660332B2May 30, 2023
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus
UNIV PENNSYLVANIA0 citations55
KARIKO KATALIN
3 patentsUS8691966B2Apr 8, 2014
RNA containing modified nucleosides and methods of use thereof
KARIKO KATALIN230 citations98
US8278036B2Oct 2, 2012
RNA containing modified nucleosides and methods of use thereof
KARIKO KATALIN564 citations98
US9012219B2Apr 21, 2015
RNA preparations comprising purified modified RNA for reprogramming cells
KARIKO KATALIN116 citations97